MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

GYRE THERAPEUTICS, INC. (GYRE)

GYRE THERAPEUTICS, INC. (GYRE)

|||

Balance Sheets Overview

Current Ratio
425.89%
Quick Ratio
386.02%
Cash Ratio
151.02%
Debt to Asset Ratio
17.23%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Long-term certificates of deposi...
    • Accounts receivables, net
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Noncontrolling interest
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
43,287
37,501
37,070
40,402
Short-term bank deposits
14,058
12,307
15,355
19,647
Short-term investment
17,451
-
-
-
Notes receivable
232
3,817
5,638
693
Accounts receivables, net
27,760
22,763
31,078
25,877
Other receivables from gni
255
230
230
230
Inventories, net
11,428
-
-
-
Inventories
-
11,352
10,171
8,854
Prepaid assets
-
-
1,338
-
Receivable from gcbp-GCBiopharma Corp
-
-
0
0
Other current assets
-
-
1,489
-
Prepaid assets and other current assets
7,601
3,762
-
2,873
Total current assets
122,072
91,732
102,369
98,576
Property and equipment, gross
39,984
31,738
31,175
30,542
Less accumulated depreciation
12,700
8,166
7,576
6,934
Property and equipment, net
27,284
23,572
23,599
23,608
2026
-
-
694
-
2027
-
-
690
-
2028
-
-
661
-
2029
-
-
659
-
2030
-
-
648
-
Gross carrying amount
5,938
5,843
-
5,687
Thereafter
-
-
1,375
-
Accumulated amortization
1,413
1,216
-
840
Intangible assets, net
4,525
4,627
4,727
4,847
Right-of-use assets
-
-
1,131
-
Land use rights, net
-
-
1,425
-
Long-term prepayments
302
-
-
-
Deferred tax assets
9,284
7,723
6,873
6,714
Long-term certificates of deposit
28,444
29,419
23,516
20,317
Other assets, noncurrent
7,344
4,942
2,492
5,322
Total assets
199,255
162,015
166,132
159,384
Accounts payable
1,236
265
124
556
Contract liabilities
-
-
14
58
Due to related parties
5,085
226
227
228
Accrued expenses and other current liabilities
18,810
15,415
14,345
11,799
Income tax payable
2,147
3,131
2,940
2,646
Operating lease liabilities, current
1,385
751
636
626
Cvr derivative liability
-
-
-
0
Total current liabilities
28,663
19,788
18,286
15,913
Operating lease liabilities, noncurrent
2,033
72
303
539
Deferred government grants
829
840
852
866
Warrant liability, noncurrent
2,741
2,872
2,961
3,224
Other noncurrent liabilities
70
1,458
1,448
1,427
Total liabilities
34,336
25,030
23,850
21,969
Temporary equity, carrying amount-Series BPreferred Stock
22,430
-
-
-
Temporary equity, carrying amount-Redeemable Convertible Preferred Stock
0
-
-
-
Redeemable convertible preferred stock-Cullgen-Redeemable Convertible Preferred Stock
0
-
-
-
Common stock, 0.001 par value, 400,000,000 shares authorized 106,033,763 shares and 91,314,007 shares issued and outstanding at june 30, 2026 and december 31, 2025, respectively
106
91
91
91
Additional paid-in capital
240,644
174,651
172,047
167,134
Statutory reserve
3,648
3,648
3,098
3,098
Accumulated deficit
-137,962
-77,667
-68,426
-66,703
Accumulated other comprehensive income (loss)
1,492
586
-779
-1,700
Total gyre stockholders' equity
107,928
101,309
106,031
101,920
Noncontrolling interest
34,561
35,676
36,251
35,495
Total equity
142,489
136,985
142,282
137,415
Total liabilities, series b preferred stock, redeemable convertible preferred stock, and stockholders' equity
199,255
162,015
166,132
159,384
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$43,287K (18.62%↑ Y/Y)Accounts receivables,net$27,760K (12.71%↑ Y/Y)Short-term investment$17,451K Short-term bank deposits$14,058K (-21.35%↓ Y/Y)Inventories, net$11,428K (28.97%↑ Y/Y)Prepaid assets and othercurrent assets$7,601K (181.41%↑ Y/Y)Other receivablesfrom gni$255K (10.87%↑ Y/Y)Notes receivable$232K (-53.51%↓ Y/Y)Property and equipment,gross$39,984K (34.06%↑ Y/Y)Gross carrying amount$5,938K Total current assets$122,072K (33.73%↑ Y/Y)Long-term certificates ofdeposit$28,444K (32.13%↑ Y/Y)Property and equipment,net$27,284K (16.59%↑ Y/Y)Deferred tax assets$9,284K (51.35%↑ Y/Y)Other assets,noncurrent$7,344K (37.63%↑ Y/Y)Intangible assets, net$4,525K (-8.81%↓ Y/Y)Long-term prepayments$302K Less accumulateddepreciation$12,700K (97.67%↑ Y/Y)Accumulated amortization$1,413K Total assets$199,255K (30.53%↑ Y/Y)Total liabilities,series b preferred...$199,255K (30.53%↑ Y/Y)Total equity$142,489K (10.08%↑ Y/Y)Total liabilities$34,336K (47.98%↑ Y/Y)Temporary equity,carrying amount-Series...$22,430K Total gyrestockholders' equity$107,928K (17.28%↑ Y/Y)Noncontrolling interest$34,561K (-7.63%↓ Y/Y)Total currentliabilities$28,663K (69.40%↑ Y/Y)Warrant liability,noncurrent$2,741K (-14.37%↓ Y/Y)Operating leaseliabilities, noncurrent$2,033K (163.68%↑ Y/Y)Deferred governmentgrants$829K (-6.22%↓ Y/Y)Other noncurrentliabilities$70K (-95.09%↓ Y/Y)Accumulated deficit-$137,962K (-96.21%↓ Y/Y)Additional paid-in capital$240,644K (49.06%↑ Y/Y)Accrued expenses andother current...$18,810K (26.04%↑ Y/Y)Due to relatedparties$5,085K (2221.92%↑ Y/Y)Income tax payable$2,147K (98.06%↑ Y/Y)Operating leaseliabilities, current$1,385K (122.67%↑ Y/Y)Accounts payable$1,236K (1640.85%↑ Y/Y)Statutory reserve$3,648K (17.75%↑ Y/Y)Accumulated othercomprehensive income (loss)$1,492K (165.24%↑ Y/Y)Common stock, 0.001 parvalue, 400,000,000...$106K (16.48%↑ Y/Y)